BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 17, 2009
View Archived Issues
Amgen scientists describe new Smo receptor antagonists in recent patent
Read More
New BACE inhibitors reported in recent Boehringer Ingelheim patent
Read More
Gilead reports data on boosting activity of fixed-dose combination therapy with GS-9350
Read More
New histamine H3 receptor ligands reported in recent High Point patent
Read More
Dainippon Sumitomo Pharma scientists claim new renin inhibitors
Read More
Bristol-Myers Squibb reports new SERT inhibitors and/or NK1 receptor antagonists
Read More
Shionogi updates Q3 progress
Read More
New HCV NS3/NS4A inhibitors discovered at Gilead
Read More
BMS researchers design novel chemokine CCR1 antagonists
Read More
Roche presents bifunctional HIV entry inhibitor CD4-BFFI
Read More
PROVE2: Telaprevir improves efficacy of hepatitis C treatment
Read More
Biodistribution, toxicity of suicide gene adenovirus therapy studied in vivo
Read More
PRO-140 shows potent and prolonged antiviral activity in HIV-1 infected individuals
Read More
Novel HIV-1 antiretroviral agents inhibit RNase H activity of viral reverse transcriptase
Read More
BioAlliance seeks E.U. MAA for fast-dissolving ondansetron
Read More
arGentis receives E.U. orphan drug designation for ARG-201
Read More
Agenix progresses ThromboView to final development stage
Read More
Diamyd receives approval for follow-up study for its diabetes vaccine
Read More
GlaxoSmithKline and Mitsubishi Tanabe to co-promote Adoair in Japan
Read More
Vical receives milestone payment from AnGes for Allovectin-7 phase III trial
Read More
Shionogi presents positive top-line efficacy results from velneperit studies
Read More
NeuroSearch enters ion channel target development alliance with Lilly
Read More
Northwest reports data from phase I and phase I/II clinical trials of DCVax-Brain
Read More
Proteo reports results from clinical study of Elafin in ARDS patients
Read More
